Eden Prairie, Minn.-based Rhythm Xience makes a line of transseptal crossing and steerable introducer systems including the Flextra, Guider and Lancer devices, which are all 510(k)-cleared by the FDA.
“At Acutus, we are challenging the status quo by building a suite of next generation products on an open platform that improves EP lab efficiency and effectiveness,” CEO CEO Vince Burgess said in prepared remarks. “Our dynamic business model addresses the entire patient care continuum and is elevating electrophysiology. We are positioned to become the only focused arrhythmia care company with a complete suite of solutions that electrophysiologists need to diagnose, treat and follow patients with atrial arrhythmias.”
Carlsbad, Calif.-based Acutus said it also inked a deal with Peerbridge Health to offer its Peerbridge Cor ambulatory ECG and another with Cardiac Designs to offer longer-term remote monitoring with the Acutus QCheck handheld ECG and mobile app. And the company agreed to distribute MedFact‘s RF ablation catheter, which is used with the robotic navigation system made by Stereotaxis (NSDQ:STXS).
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.